Global Eliquis Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Eliquis market report explains the definition, types, applications, major countries, and major players of the Eliquis market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    By Type:

    • 25 mg

    • 5 mg

    By End-User:

    • Deep Vein Thrombosis (DVT)

    • Pulmonary Embolism (PE)

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Eliquis Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Eliquis Outlook to 2028- Original Forecasts

    • 2.2 Eliquis Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Eliquis Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Eliquis Market- Recent Developments

    • 6.1 Eliquis Market News and Developments

    • 6.2 Eliquis Market Deals Landscape

    7 Eliquis Raw Materials and Cost Structure Analysis

    • 7.1 Eliquis Key Raw Materials

    • 7.2 Eliquis Price Trend of Key Raw Materials

    • 7.3 Eliquis Key Suppliers of Raw Materials

    • 7.4 Eliquis Market Concentration Rate of Raw Materials

    • 7.5 Eliquis Cost Structure Analysis

      • 7.5.1 Eliquis Raw Materials Analysis

      • 7.5.2 Eliquis Labor Cost Analysis

      • 7.5.3 Eliquis Manufacturing Expenses Analysis

    8 Global Eliquis Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Eliquis Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Eliquis Export by Region (Top 10 Countries) (2017-2028)

    9 Global Eliquis Market Outlook by Types and Applications to 2022

    • 9.1 Global Eliquis Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 25 mg Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global 5 mg Consumption and Growth Rate (2017-2022)

    • 9.2 Global Eliquis Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Deep Vein Thrombosis (DVT) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pulmonary Embolism (PE) Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Eliquis Market Analysis and Outlook till 2022

    • 10.1 Global Eliquis Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Eliquis Consumption (2017-2022)

      • 10.2.2 Canada Eliquis Consumption (2017-2022)

      • 10.2.3 Mexico Eliquis Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Eliquis Consumption (2017-2022)

      • 10.3.2 UK Eliquis Consumption (2017-2022)

      • 10.3.3 Spain Eliquis Consumption (2017-2022)

      • 10.3.4 Belgium Eliquis Consumption (2017-2022)

      • 10.3.5 France Eliquis Consumption (2017-2022)

      • 10.3.6 Italy Eliquis Consumption (2017-2022)

      • 10.3.7 Denmark Eliquis Consumption (2017-2022)

      • 10.3.8 Finland Eliquis Consumption (2017-2022)

      • 10.3.9 Norway Eliquis Consumption (2017-2022)

      • 10.3.10 Sweden Eliquis Consumption (2017-2022)

      • 10.3.11 Poland Eliquis Consumption (2017-2022)

      • 10.3.12 Russia Eliquis Consumption (2017-2022)

      • 10.3.13 Turkey Eliquis Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Eliquis Consumption (2017-2022)

      • 10.4.2 Japan Eliquis Consumption (2017-2022)

      • 10.4.3 India Eliquis Consumption (2017-2022)

      • 10.4.4 South Korea Eliquis Consumption (2017-2022)

      • 10.4.5 Pakistan Eliquis Consumption (2017-2022)

      • 10.4.6 Bangladesh Eliquis Consumption (2017-2022)

      • 10.4.7 Indonesia Eliquis Consumption (2017-2022)

      • 10.4.8 Thailand Eliquis Consumption (2017-2022)

      • 10.4.9 Singapore Eliquis Consumption (2017-2022)

      • 10.4.10 Malaysia Eliquis Consumption (2017-2022)

      • 10.4.11 Philippines Eliquis Consumption (2017-2022)

      • 10.4.12 Vietnam Eliquis Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Eliquis Consumption (2017-2022)

      • 10.5.2 Colombia Eliquis Consumption (2017-2022)

      • 10.5.3 Chile Eliquis Consumption (2017-2022)

      • 10.5.4 Argentina Eliquis Consumption (2017-2022)

      • 10.5.5 Venezuela Eliquis Consumption (2017-2022)

      • 10.5.6 Peru Eliquis Consumption (2017-2022)

      • 10.5.7 Puerto Rico Eliquis Consumption (2017-2022)

      • 10.5.8 Ecuador Eliquis Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Eliquis Consumption (2017-2022)

      • 10.6.2 Kuwait Eliquis Consumption (2017-2022)

      • 10.6.3 Oman Eliquis Consumption (2017-2022)

      • 10.6.4 Qatar Eliquis Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Eliquis Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Eliquis Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Eliquis Consumption (2017-2022)

      • 10.7.2 South Africa Eliquis Consumption (2017-2022)

      • 10.7.3 Egypt Eliquis Consumption (2017-2022)

      • 10.7.4 Algeria Eliquis Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Eliquis Consumption (2017-2022)

      • 10.8.2 New Zealand Eliquis Consumption (2017-2022)

    11 Global Eliquis Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer Eliquis Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Eliquis Main Business and Markets Served

      • 11.1.4 Pfizer Eliquis Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    12 Global Eliquis Market Outlook by Types and Applications to 2028

    • 12.1 Global Eliquis Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 25 mg Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global 5 mg Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Eliquis Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Deep Vein Thrombosis (DVT) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pulmonary Embolism (PE) Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Eliquis Market Analysis and Outlook to 2028

    • 13.1 Global Eliquis Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Eliquis Consumption Forecast (2022-2028)

      • 13.2.2 Canada Eliquis Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Eliquis Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Eliquis Consumption Forecast (2022-2028)

      • 13.3.2 UK Eliquis Consumption Forecast (2022-2028)

      • 13.3.3 Spain Eliquis Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Eliquis Consumption Forecast (2022-2028)

      • 13.3.5 France Eliquis Consumption Forecast (2022-2028)

      • 13.3.6 Italy Eliquis Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Eliquis Consumption Forecast (2022-2028)

      • 13.3.8 Finland Eliquis Consumption Forecast (2022-2028)

      • 13.3.9 Norway Eliquis Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Eliquis Consumption Forecast (2022-2028)

      • 13.3.11 Poland Eliquis Consumption Forecast (2022-2028)

      • 13.3.12 Russia Eliquis Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Eliquis Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Eliquis Consumption Forecast (2022-2028)

      • 13.4.2 Japan Eliquis Consumption Forecast (2022-2028)

      • 13.4.3 India Eliquis Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Eliquis Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Eliquis Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Eliquis Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Eliquis Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Eliquis Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Eliquis Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Eliquis Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Eliquis Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Eliquis Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Eliquis Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Eliquis Consumption Forecast (2022-2028)

      • 13.5.3 Chile Eliquis Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Eliquis Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Eliquis Consumption Forecast (2022-2028)

      • 13.5.6 Peru Eliquis Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Eliquis Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Eliquis Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Eliquis Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Eliquis Consumption Forecast (2022-2028)

      • 13.6.3 Oman Eliquis Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Eliquis Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Eliquis Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Eliquis Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Eliquis Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Eliquis Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Eliquis Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Eliquis Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Eliquis Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Eliquis Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Eliquis

    • Figure of Eliquis Picture

    • Table Global Eliquis Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Eliquis Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 25 mg Consumption and Growth Rate (2017-2022)

    • Figure Global 5 mg Consumption and Growth Rate (2017-2022)

    • Figure Global Deep Vein Thrombosis (DVT) Consumption and Growth Rate (2017-2022)

    • Figure Global Pulmonary Embolism (PE) Consumption and Growth Rate (2017-2022)

    • Figure Global Eliquis Consumption by Country (2017-2022)

    • Table North America Eliquis Consumption by Country (2017-2022)

    • Figure United States Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Canada Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Mexico Eliquis Consumption and Growth Rate (2017-2022)

    • Table Europe Eliquis Consumption by Country (2017-2022)

    • Figure Germany Eliquis Consumption and Growth Rate (2017-2022)

    • Figure UK Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Spain Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Belgium Eliquis Consumption and Growth Rate (2017-2022)

    • Figure France Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Italy Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Denmark Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Finland Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Norway Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Sweden Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Poland Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Russia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Turkey Eliquis Consumption and Growth Rate (2017-2022)

    • Table APAC Eliquis Consumption by Country (2017-2022)

    • Figure China Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Japan Eliquis Consumption and Growth Rate (2017-2022)

    • Figure India Eliquis Consumption and Growth Rate (2017-2022)

    • Figure South Korea Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Thailand Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Singapore Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Philippines Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Eliquis Consumption and Growth Rate (2017-2022)

    • Table South America Eliquis Consumption by Country (2017-2022)

    • Figure Brazil Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Colombia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Chile Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Argentina Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Peru Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Eliquis Consumption and Growth Rate (2017-2022)

    • Table GCC Eliquis Consumption by Country (2017-2022)

    • Figure Bahrain Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Oman Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Qatar Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Eliquis Consumption and Growth Rate (2017-2022)

    • Table Africa Eliquis Consumption by Country (2017-2022)

    • Figure Nigeria Eliquis Consumption and Growth Rate (2017-2022)

    • Figure South Africa Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Egypt Eliquis Consumption and Growth Rate (2017-2022)

    • Figure Algeria Eliquis Consumption and Growth Rate (2017-2022)

    • Table Oceania Eliquis Consumption by Country (2017-2022)

    • Figure Australia Eliquis Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Eliquis Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer Eliquis Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Eliquis Main Business and Markets Served

    • Table Pfizer Eliquis Product Portfolio

    • Figure Global 25 mg Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 5 mg Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Deep Vein Thrombosis (DVT) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pulmonary Embolism (PE) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Eliquis Consumption Forecast by Country (2022-2028)

    • Table North America Eliquis Consumption Forecast by Country (2022-2028)

    • Figure United States Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Eliquis Consumption Forecast by Country (2022-2028)

    • Figure Germany Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Eliquis Consumption Forecast by Country (2022-2028)

    • Figure China Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Eliquis Consumption Forecast by Country (2022-2028)

    • Figure Brazil Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Eliquis Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Eliquis Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Eliquis Consumption Forecast by Country (2022-2028)

    • Figure Australia Eliquis Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Eliquis Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.